CASI PHARMACEUTICALS, INC. Accounts Receivable, Allowance for Credit Loss, Current
CASI PHARMACEUTICALS, INC. (CASIF) had Accounts Receivable, Allowance for Credit Loss, Current of $0 as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-05-15
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2022-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2021-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2024-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2022-12-31 | $0.00 20-F · filed 2023-04-26 |
| 2021-12-31 | $0.00 20-F · filed 2023-04-26 |